Catalogo dei prodotti della ricerca

AUTORE, Camillo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.660
EU - Europa 2.063
AS - Asia 1.185
AF - Africa 46
SA - Sud America 35
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.612
IT - Italia 746
SG - Singapore 570
IN - India 346
SE - Svezia 279
UA - Ucraina 203
CN - Cina 191
FI - Finlandia 182
DE - Germania 169
AT - Austria 106
IE - Irlanda 76
BG - Bulgaria 55
GB - Regno Unito 55
RU - Federazione Russa 44
FR - Francia 39
TG - Togo 37
CA - Canada 36
ID - Indonesia 36
RO - Romania 29
AR - Argentina 21
AU - Australia 16
NL - Olanda 16
BE - Belgio 15
MX - Messico 12
TR - Turchia 8
GR - Grecia 6
RS - Serbia 6
CH - Svizzera 5
CO - Colombia 5
MD - Moldavia 5
PT - Portogallo 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
CL - Cile 4
ES - Italia 4
HK - Hong Kong 4
KR - Corea 4
BA - Bosnia-Erzegovina 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
IR - Iran 3
DK - Danimarca 2
EE - Estonia 2
LT - Lituania 2
PH - Filippine 2
PK - Pakistan 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BJ - Benin 1
BO - Bolivia 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
JP - Giappone 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 10.007
Salva come PNG Salva come JPEG
Città #
Fairfield 1.017
Woodbridge 567
Chandler 487
Ashburn 456
Singapore 415
Seattle 411
Houston 406
Cambridge 357
Wilmington 357
Rome 242
Princeton 190
Ann Arbor 186
Santa Clara 180
San Paolo di Civitate 153
Plano 147
Lawrence 136
Beijing 113
Boston 103
Vienna 93
San Diego 88
Millbury 82
Jacksonville 81
Dearborn 78
Des Moines 61
New York 57
Andover 55
Sofia 55
Dublin 54
Helsinki 42
Lomé 37
Jakarta 36
Norwalk 34
Boardman 32
Milan 31
Moscow 25
Los Angeles 23
Toronto 23
Falls Church 21
Fremont 21
Federal 20
Brussels 15
Bühl 15
Bremen 13
Frankfurt am Main 12
Palermo 11
San Mateo 11
Lappeenranta 10
London 10
Mannheim 10
Adelaide 9
Falkenstein 9
Hefei 9
Pune 9
Kunming 8
Shanghai 8
Auburn Hills 7
Dallas 7
Florence 7
Nanjing 7
Ottawa 7
Colorado Springs 6
Simi Valley 6
Washington 6
Bergamo 5
Chisinau 5
Guangzhou 5
Istanbul 5
Menlo Park 5
Oxford 5
Redmond 5
Bari 4
Bologna 4
Calcio 4
Chongqing 4
Genova 4
Hong Kong 4
Indiana 4
Jinan 4
Laurel 4
Mexico City 4
Militello in Val di Catania 4
Nellore 4
Nocera Inferiore 4
Padova 4
Paris 4
Porto 4
Provo 4
Redwood City 4
Scafati 4
Thessaloniki 4
Trieste 4
Acerra 3
Bogotá 3
Grafing 3
Leawood 3
Montréal 3
Munich 3
Palestrina 3
Parma 3
Philadelphia 3
Totale 7.330
Salva come PNG Salva come JPEG
Nome #
Admission heart rate and in-hospital course of patients with Takotsubo syndrome 138
Mutations in the GLA gene and LysoGb3. Is it really anderson-fabry disease 112
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 109
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort 105
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy 100
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 94
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 93
null 91
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 90
Anomalie cardiovascolari in un paziente con sospetta sindrome di Hennekam 89
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal. 89
Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy 86
Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome 86
A case of thrombolysis in acute pulmonary embolism with right atrial thrombus: comparing current and past guidelines 85
Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions. 84
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T > C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy 83
Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine 83
Long-term management of Takotsubo syndrome: a not-so-benign condition 82
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms 81
Erythropoietin and the heart: facts and perspectives. 81
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy 80
Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? 79
QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly 79
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing 79
Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction 79
Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy 78
Syncope and risk of sudden death in hypertrophic cardiomyopathy 78
Aspetti immunologici delle miocardiopatie ipertrofiche primitive 77
Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents. 76
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes 76
Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis 75
Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features 75
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy 75
Electrocardiographic diagnosis of left ventricular hypertrophy in the presence of left bundle branch block: a wasted effort. 74
Cardiologic assesment of surviving family members of young victims of sudden cardiac death: diagnostic yeld. 74
Patterns of left ventricular longitudinal strain and strain rate in Olympic athletes 74
Combined use of dobutamine echocardiography and myocardial contrast echocardiography in predicting regional dysfunction recovery after coronary revascularization in patients with recent myocardial infarction 73
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 73
Risk associated with pregnancy in hypertrophic cardiomyopathy. 72
Limitations of the electrocardiographic diagnosis of left ventricular hypertrophy: the influence of left anterior hemiblock and right bundle branch block 72
IL TRATTAMENTO DELLE DISLIPIDEMIE NELLA PREVENZIONE PRIMARIA DELLE MALATTIE CARDIOVASCOLARI: LE INDICAZIONI PER LA PRATICA CLINICA 72
HLA-DR3 ANTIGEN LINKAGE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY 71
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 71
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey 71
Recombinant human insulin-like growth factor-1: a new cardiovascolar disease treatment option? 70
Pulmonary embolism in pregnancy 69
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress? 69
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New outlook and dose association study (EPAMINONDAS) 68
null 68
Electrocardiographic changes in focal takotsubo syndrome. a case report 68
Approach to Hypertrophic Cardiomyopathy. 67
null 67
Noninvasive assessment of myocardial perfusion: preliminary results in patients with acute myocardial infarction 67
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy. a systematic review and meta-analysis 67
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 67
Three-Dimensional Echocardiographic Characterization of Patients with Left Ventricular Noncompaction 66
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy. a systematic review and meta-analysis 66
Simultaneous Takotsubo syndrome in two sisters 66
Mitochondrial tRNA mutations manifest not only as hypertrophic cardiomyopathy but also as noncompaction-reply 65
Long-Term Outcome of Acute Coronary Syndromes in Young Patients 65
Clinical Course and Quality of Life in High-Risk Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators 65
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm 65
Accuracy of the "International Criteria" for ECG screening in athletes in comparison with previous published criteria. Rationale and design of a diagnostic meta-analysis 65
Severe Left Ventricular Wall Thinning and Extensive Fibrosis Without Evolution to End Stage Disease in a Patient With Hypertrophic Cardiomyopathy 64
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man. 64
Epidural anesthesia for cesarean section in patients with hypertrophic cardiomyopathy: A report of three cases 62
Management of hypertrophic cardiomyopathy 62
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 62
Epidemiology and patterns of care of patients admitted to Italian Intensive Cardiac Care units: The BLITZ-3 registry 61
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy 61
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study 61
Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey 61
Unexpectedly Low Mutation Rates in Beta-Myosin Heavy Chain and Cardiac Myosin Binding Protein Genes in Italian Patients With Hypertrophic Cardiomyopathy 61
Clinical translation of genetic testing in TTR Amyloidosis. genotype-phenotype correlations, management of asymptomatic carriers and familial screening 60
Role of echocardiography in acute chest pain syndrome 60
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 60
Ropivacaine: drug of choice? Or not? 59
Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates 59
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 58
Hypertrophic cardiomyopathy in a patient with Down's syndrome. 57
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors 57
Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing 57
Non-invasive evaluation of left ventricular function in myotonic dystrophy 56
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 56
Non-alcoholic fatty liver disease and heart valve disease. A neglected link 56
Spatial QT dispersion predicts non-sustained ventricula tachycardia and correlates with a confined systo-diastolic dysfunction un hypertrophic cardiomyopathy 55
Sex-related differences in cardiomyopathies 55
null 54
Left ventricular myocardial function in myotonic dystrophy 54
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy 54
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy 54
Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy 54
cardiomiopatia mitocondriale: una nuova entità nel campo della ricerca e della diagnosi cardiologica 53
null 53
Prevalence, prevention and treatment of infective endocarditis in hypertrophic cardiomyopathy 52
Autoantibodies in myotonic dystrophy 52
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy 52
Maternally inherited cardiomyopathy: clinical and molecula characterization of a large kindred harboring the A4300G point mutation in mtDNA 52
Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study 52
Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence and indications for antibiotic prophylaxis 51
Totale 7.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.289 0 0 0 0 0 251 247 234 209 169 104 75
2020/2021863 91 95 37 51 38 55 51 63 82 147 123 30
2021/20221.947 38 100 181 108 278 51 48 202 111 127 340 363
2022/20231.989 347 439 168 131 213 213 38 90 144 59 107 40
2023/20241.083 67 133 39 104 112 169 41 66 6 133 106 107
2024/2025952 80 135 208 135 228 166 0 0 0 0 0 0
Totale 10.519